Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (7)

2024

  1. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

2023

  1. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

2022

  1. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

2021

  1. Tuberculosis Vaccines

    Pediatric Vaccines and Vaccinations: A European Textbook: Second Edition (Springer International Publishing), pp. 171-184

2014

  1. Erratun :Prevention of serogroup B meningococcal disease using a four-component vaccine (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013)

    Anales de Pediatria

  2. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes

    Pediatria de Atencion Primaria, Vol. 16, Núm. 62

  3. Prevention of serogroup B meningococcal disease using a four-component vaccin

    Anales de Pediatria, Vol. 80, Núm. 4